WWOX and cancer: When mice receive Zfra peptide followed by inoculation with cancer cells, there is a significant reduction in WWOX phosphorylation at T12, S14, Y33, and Y61 in WWOX in the spleen cells in one to two months (data not shown for T12 and S14).